Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Brian O’Neill, Bryan Zweig, Ryan Gindi Start date: Apr 03, 2025
Join us for an exclusive webinar, part of the Beyond the Heartbeat series, that delves into the latest advancements in mitral and tricuspid regurgitation treatment. Our expert panel will equip you with details related to groundbreaking clinical trial data and practical insights to enhance your professional practice.Learning Objectives:Explore Proven Therapies: Discover recent clinical data from… View more
Research Area(s) / Expertise: Job title: Head of the Cardiovascular Clinical Pharmacology Laboratory
Author(s): Steven E Nissen Added: 3 weeks ago
American College of Cardiology Congress 2026 – Dr Steven Nissen (Cleveland Clinic, Cleveland, OH, US) joins us to discuss the effects of tirzepatide compared with dulaglutide on expanded cardiorenal outcomes from the SURPASS-CVOT trial (NCT04255433; Eli Lilly and Company).This international, double-blind, randomised, phase III cardiovascular outcomes trial enrolled 13,299 patients aged 40 and… View more
Added: 7 months ago Source:  HFSA 2025 Scientific Programme
HSFA Annual Scientific Meeting 2025 has released its late-breaking clinical research sessions which are to be presented in September 2025.The meeting is set to take place from the 26th to 29th September 2025 at Minneapolis Convention Center in Minnesota, US.Access the full programme here.Late Breaking Clinical Research 1: Devices and CardiomyopathiesSunday 28th September, 09:00am – 10:30am (CDT… View more
Added: 9 months ago Source:  ESC Congress 2025 Scientific Programme
Ten hot line sessions have been announced for ESC Congress 2025.The congress is set to take place from the 29th August to 1st September at IFEMA - Fiera de Madrid.Access the full programme here.Hot Line 1Friday 29th August, 11:00am – 12:00pm (CEST)POTCAST – a Randomized Controlled Trial of Arrhythmia prevention using targeted plasma potassium levels in ICD Patients – Presented by Christian… View more
Klaus Witte is a Cardiologist at the Leeds Institute of Cardiovascular & Metabolic Medicine, Leeds, UK, where his research group focuses on patient-orientated questions with a commitment to enhancing efficacy through the personalised application of new and existing therapies in chronic heart failure (CHF).Challenging conventional teaching around heart rate and exercise capacity in CHF, Dr Witte’s… View more